# Scar-Improvement Efficacy and Safety of a Single Intradermal Injection of Avotermin (Juvista) Administered Following Full-Thickness Skin Incisions

> **NCT00627536** · PHASE2 · COMPLETED · sponsor: **Renovo** · enrollment: 39 (actual)

## Conditions studied

- Cicatrix

## Interventions

- **DRUG:** Avotermin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00627536
- **Lead sponsor:** Renovo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00627536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00627536, "Scar-Improvement Efficacy and Safety of a Single Intradermal Injection of Avotermin (Juvista) Administered Following Full-Thickness Skin Incisions". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00627536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*